Spire Healthcare (S00) Stock Price & Analysis
S00 Stock Chart & Stats
- Day’s Range
- EUR 2.82 - EUR 3.12
- 52-Week Range
- EUR 1.50 - EUR 3.12
- Previous Close
- EUR 2.82
- Volume
- 0
- Average Volume (3M)
- 123
- Market Cap
- EUR 1.20B
- Enterprise Value
- EUR 2.14B
- Total Cash (Recent Filing)
- EUR 29.80M
- Total Debt (Recent Filing)
- EUR 1.31B
- Price to Earnings (P/E)
- ―
- Beta
- -0.03
- Next Earnings
- Mar 04, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 0.57%
Bulls Say, Bears Say
Bulls Say
Sustained Revenue Expansion
The substantial multi-year revenue increase indicates durable demand for Spire’s private healthcare, diagnostics and publicly funded services. Continued volume growth gives the group a broader base over which to spread hospital and clinical operating costs.
Consistent Positive Cash Generation
Positive operating and free cash flow provide internal funding for hospital investment, debt service and ongoing operations. The improvement through 2025 supports financial flexibility and reduces reliance on external capital to maintain the care network.
Stable Operating Profitability
Stable operating and EBITDA margins suggest that Spire has retained reasonable control of core delivery costs despite operating complexity. Sustained profitability at the operating level supports the resilience of its hospital and clinic model.
Bears Say
Elevated Leverage
High leverage leaves less balance-sheet protection if patient volumes, reimbursement or margins weaken. It can also increase sensitivity to financing costs and restrict capital allocation, making expansion and investment more dependent on cash-flow stability.
Weak Net-Income Conversion
Very thin net margins leave limited room to absorb higher labour, operating, interest or tax costs. The decline in net income despite steady operating margins indicates that earnings conversion remains structurally weaker than the underlying revenue and EBITDA performance.
Limited Cash-Flow Headroom
Although cash generation is positive, moderate obligation coverage indicates limited resilience if operating cash flow deteriorates. Free cash flow below reported earnings also suggests that accounting profits do not consistently translate into cash available for debt reduction or reinvestment.
Spire Healthcare News
S00 FAQ
What was Spire Healthcare’s price range in the past 12 months?
What is Spire Healthcare’s market cap?
When is Spire Healthcare’s upcoming earnings report date?
How were Spire Healthcare’s earnings last quarter?
Is Spire Healthcare overvalued?
Does Spire Healthcare pay dividends?
What is Spire Healthcare’s EPS estimate?
How many shares outstanding does Spire Healthcare have?
What happened to Spire Healthcare’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Spire Healthcare?
What is the TipRanks Smart Score and how is it calculated?
Spire Healthcare Stock Smart Score
Company Description
Spire Healthcare
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Justin Ash
- Employees
- 17,800
- Website
- www.spirehealthcare.com
- Address
- 3 Dorset Rise, London, GL, EC4Y 8EN, GB
Spire Healthcare (S00) Earnings & Revenues
S00 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 16 | 3 | 3 |
| Technical Analysis | 4 | 3 | 3 |
| Moving Averages | 12 | 0 | 0 |